World Healthy Lifestyle Awareness Day: The Power of AI for Personalised Health
By Sumona Bose
February 15, 2024
Introduction
In today’s fast-paced world, where hectic schedules and demanding lifestyles have become the norm, maintaining a healthy lifestyle has never been more important. As we commemorate World Healthy Lifestyle Awareness Day (15th of February), it is crucial to recognise the role that artificial intelligence (AI) and Machine Learning (ML). ML is a subset of AI which can be positioned to differentiate between correct and incorrect categorisations. The power of AI in personalised health can improve our attitudes towards health accordingly.
AI has made significant strides in recent years, enabling the development of sophisticated applications and tools that can assess trends in outcome-based research. AI advancements pave the way for healthcare interventions such as biological evaluations, diagnostics and predictions through devices. This has led to a more personalised collection of data and real-time feedback from customers.
Figure 1: A schematic representation of the most commonly known AI methods.
Nutrition Assessments and AI
One area where AI can have a profound impact is in nutrition assessments. By collecting and evaluating data about dietary intake, AI systems can provide tailored diets that fit an individual’s behaviours. Factors such as age, gender, microbiota, genetics, metabolism, and lifestyle habits can all influence how individuals respond to food nutrients. The adoption of AI in the field of nutrition could pave the way for the development of personalised nutrition plans. This can eventually lead to better health outcomes at both the individual and national levels. AI technologies can enable precise customised dietary recommendations and promote health through predictive and preventive guidelines. This facilitates the management of diseases in a more effective manner.
AI Enabling Holistic Health Interventions
AI can assist physicians in selecting appropriate therapies, adjusting doses in a timely manner, and identifying patients who require more comprehensive or urgent examinations. By reducing the time spent in face-to-face visits and streamlining healthcare processes, AI can alleviate the workload of physicians and decrease waiting times in medical centres. This, in turn, can lead to a reduction in overall healthcare costs. The power of AI in personalised health delivers context specific health outcomes.
Conclusion
It is important to address certain challenges, related to patient privacy whilst acknowledging AI’s utility. Healthcare institutions and research collaborations produce methods in which AI is implemented responsibly and ethically. As we celebrate World Healthy Lifestyle Awareness Day, let us celebrate AI and personalised healthcare.
🚀 Are pharmaceutical companies’ DTC telehealth partnerships reshaping healthcare for better or worse?
Recent findings from the “DTC Investigation 2025” report reveal key insights into the high prescription rates and potential risks of these digital platforms operated by giants like Pfizer and Eli Lilly. Alarmingly, inadequate clinical safeguards raise questions about patient safety, prescribing practices, and cost implications.
Dive into this critical discussion about the intersection of digital health and pharmaceutical practices, and explore what it means for the future of patient care.
🌟 How can personalized medicine transform breast cancer treatment in Spain?
The recent rollout of the MAF Test breast cancer in leading Spanish hospitals is set to revolutionize patient care by enabling targeted treatment strategies. This innovative molecular assay not only identifies patients who will benefit from bisphosphonates but also spares those for whom the treatment may be harmful, ultimately improving outcomes for thousands.
Dive into the article to discover how this approach aligns with global trends in oncology and enhances healthcare resource allocation.
🌟 Are we on the brink of transforming breast cancer treatment?
NICE’s latest guidance endorsing ribociclib in combination with an aromatase inhibitor marks a significant advancement for adults facing high-risk early breast cancer. This decision not only promises enhanced survival outcomes but also expands treatment options for patients historically limited to conventional therapies.
Dive into the details of this important development and learn how it may revolutionize patient care in the oncology landscape.
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.
